1-3 of 3
Maritza Lienlaf, MS
Close
Sort by
Journal Articles

Selective Inhibition of HDAC6 Decreases Viability of Cutaneous T-Cell Lymphoma and Improves Immune Recognition

Tessa Knox, MS, Maritza Lienlaf, MS, Patricio Perez-Villarroel, BS., Calvin Lee, MD, Eva Sahakian, PhD, John J. Powers, B.S., Fengdong Cheng, MD, Jorge Canales, MS, Danay Marante, MS, Ed Seto, PhD, Eduardo M. Sotomayor, MD, Alejandro Villagra, PhD, Pedro Horna, MD
Journal: Blood
Blood (2014) 124 (21): 5423.
https://doi.org/10.1182/blood.V124.21.5423.5423
Published: 2014
Journal Articles

A Phase I/II Trial Evaluating the Use of a Histone Deacetylase Inhibitor Panobinostat (LBH589) in Addition to Glucocorticoids in Patients with Acute Graft-Versus-Host Disease

Lia Perez, MD, Teresa Field, MD PhD, Marcie L Riches, MD MS, Hugo F Fernandez, MD, Frederick L Locke, MD, Brian C Betts, MD, Joseph Pidala, MD PhD, Erika Elmer, CCRP, Francisca Beato, BS, Maritza Lienlaf, MS, Pedro Horna, MD, Alejandro Villagra, PhD, Claudio Anasetti, MD
Journal: Blood
Blood (2014) 124 (21): 1167.
https://doi.org/10.1182/blood.V124.21.1167.1167
Published: 2014
Journal Articles

Role Of Histone Deacetylase 6 (HDAC6) In The Modulation Of STAT Pathways and Immune Function Of APCs

Maritza Lienlaf, MS, Patricio Perez-Villarroel, BS., Fengdong Cheng, MD, Calvin K. Lee, MD, Jorge Canales, MS, Tessa Knox, MS, Danay Marante, MS, Sean J Yoder, MS, Karrune V. Woan, PhD, Javier Pinilla-Ibarz, MD, PhD, Edward Seto, PhD, Eduardo M. Sotomayor, MD, Alejandro Villagra, PhD
Journal: Blood
Blood (2013) 122 (21): 1032.
https://doi.org/10.1182/blood.V122.21.1032.1032
Published: 2013